ES2111492B1 - Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central. - Google Patents

Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central.

Info

Publication number
ES2111492B1
ES2111492B1 ES09600303A ES9600303A ES2111492B1 ES 2111492 B1 ES2111492 B1 ES 2111492B1 ES 09600303 A ES09600303 A ES 09600303A ES 9600303 A ES9600303 A ES 9600303A ES 2111492 B1 ES2111492 B1 ES 2111492B1
Authority
ES
Spain
Prior art keywords
derivatives
alkyl
compositions
central nervous
benzodiazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09600303A
Other languages
English (en)
Other versions
ES2111492A1 (es
Inventor
Pal Vago
Jozsef Reiter
Istvan Gyertyan
Gabor Gigler
Ferenc Andrasi
Anna Bakonyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of ES2111492A1 publication Critical patent/ES2111492A1/es
Application granted granted Critical
Publication of ES2111492B1 publication Critical patent/ES2111492B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

DERIVADOS DE 1-[2-VINILO SUBSTITUIDO)]-3,4-DIHIDRO-5H-2,3-BENZODIAZEPINA, PROCEDIMIENTO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y UTILIZACION DE DICHOS DERIVADOS Y COMPOSICIONES PARA EL TRATAMIENTO DE TRASTORNOS DEL SISTEMA NERVIOSO CENTRAL. LOS COMPUESTOS DE ACUERDO CON LA INVENCION CORRESPONDEN A LA FORMULA GENERAL (I). FORMULA DONDE R REPRESENTA HIDROGENO O ALCANOILO C1-4; R1 REPRESENTA FENILO QUE OPCIONALMENTE LLEVA 1-3 SUBSTITUYENTES IDENTICOS O DIFERENTES, SELECCIONADOS ENTRE EL GRUPO CONSISTENTE EN HALOGENO, NITRO, AMINO, (ALQUILO C1-4)AMINO, DI(ALQUILO C1-4)AMINO, (ALCANOILO C1-4)AMINO, ALQUILO C1-4, ALCOXI C1-4, METILENDIOXI E HIDROXI; O NAFTILO QUE OPCIONALMENTE LLEVA UN SUBSTITUYENTE SELECCIONADO ENTRE EL GRUPO CONSISTENTE EN HIDROXI, ALQUILO C1-4 Y ALCOXI C1-4; R2 REPRESENTA HIDROGENO O ALQUILO C1-4; R3 Y R4 SON, INDEPENDIENTEMENTE ENTRE SI, ALQUILO C1-4, O R3 Y R4 JUNTOS FORMAN METILENO. LOS NUEVOS COMPUESTOS DE ACUERDO CON LA INVENCION AFECTAN AL SISTEMA NERVIOSO CENTRAL Y SE PUEDEN UTILIZAR CON VENTAJA EN TERAPEUTICA.
ES09600303A 1995-02-09 1996-02-08 Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central. Expired - Fee Related ES2111492B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9500386A HU224435B1 (hu) 1995-02-09 1995-02-09 Benzodiazepin-származékok, eljárás előállításukra, alkalmazásukra és ezeket tartalmazó gyógyászati készítmények

Publications (2)

Publication Number Publication Date
ES2111492A1 ES2111492A1 (es) 1998-03-01
ES2111492B1 true ES2111492B1 (es) 1999-07-01

Family

ID=10986432

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09600303A Expired - Fee Related ES2111492B1 (es) 1995-02-09 1996-02-08 Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central.

Country Status (18)

Country Link
US (1) US6075018A (es)
JP (1) JP3354375B2 (es)
KR (1) KR960031444A (es)
BE (1) BE1009852A3 (es)
CA (1) CA2169112A1 (es)
CZ (1) CZ291218B6 (es)
ES (1) ES2111492B1 (es)
FI (1) FI960616A (es)
FR (1) FR2730490B1 (es)
GB (1) GB2297749B (es)
HR (1) HRP960065A2 (es)
HU (1) HU224435B1 (es)
IT (1) IT1282591B1 (es)
PL (1) PL312707A1 (es)
RU (1) RU2155757C2 (es)
SK (1) SK281482B6 (es)
UA (1) UA45954C2 (es)
YU (1) YU8396A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649607B2 (en) 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
MXPA05005895A (es) * 2002-12-03 2006-02-08 Vela Pharmaceuticals Inc Composicion farmaceutica de 1-(3, 4-dimetoxifenil)-4 -metil-5-etil -7-metoxi-8 -hidroxi- 5h-2, 3-benzodiacepina y usos de la misma.
CA2510275A1 (en) * 2002-12-03 2004-08-19 Vela Pharmaceuticals, Inc. Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
US6864251B2 (en) * 2002-12-03 2005-03-08 Vela Pharmaceuticals, Inc. Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
US6638928B1 (en) 2002-12-03 2003-10-28 Vela Pharmaceuticals, Inc. Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
US7022700B2 (en) * 2002-12-03 2006-04-04 Vela Pharmaceuticals, Inc. Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
US20040224943A1 (en) * 2003-02-19 2004-11-11 Leventer Steven M. Method of lowering body temperature with (R) - 2,3-benzodiazepines
PL1833815T3 (pl) * 2004-12-30 2011-03-31 Inst Farmaceutyczny Sposób wytwarzania zasady imatinibu
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE761315A (es) * 1970-01-12 1971-07-07 S M B Anciens Etablissements J
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
HU186760B (en) * 1981-03-12 1985-09-30 Gyogyszerkutato Intezet Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives
HU195788B (en) * 1986-05-21 1988-07-28 Gyogyszerkutato Intezet Process for producing 1-/hydroxy-stiryl/-5h-2,3-benzobiazepines and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FR2730490B1 (fr) 1997-04-18
PL312707A1 (en) 1996-08-19
UA45954C2 (uk) 2002-05-15
CA2169112A1 (en) 1996-08-10
FI960616A0 (fi) 1996-02-09
HU224435B1 (hu) 2005-10-28
SK281482B6 (sk) 2001-04-09
FR2730490A1 (fr) 1996-08-14
YU8396A (sh) 1998-12-23
ITMI960245A0 (es) 1996-02-09
ITMI960245A1 (it) 1997-08-09
FI960616A (fi) 1996-08-10
HRP960065A2 (en) 1997-12-31
KR960031444A (ko) 1996-09-17
US6075018A (en) 2000-06-13
GB9602690D0 (en) 1996-04-10
GB2297749B (en) 1998-07-01
ES2111492A1 (es) 1998-03-01
JP3354375B2 (ja) 2002-12-09
GB2297749A (en) 1996-08-14
BE1009852A3 (fr) 1997-10-07
JPH08283247A (ja) 1996-10-29
SK16896A3 (en) 1996-10-02
CZ37796A3 (en) 1996-08-14
RU2155757C2 (ru) 2000-09-10
IT1282591B1 (it) 1998-03-31
CZ291218B6 (cs) 2003-01-15
HU9500386D0 (en) 1995-03-28

Similar Documents

Publication Publication Date Title
BR9712085A (pt) Inibidores de metaloprotease heterocìclicos
MX9305379A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene.
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
PE20020720A1 (es) Derivados benzimidazol y piridilimidazol como ligandos para receptores gabaa
FI842419A (fi) 2-pyrimidinyl-1-piperazin-derivat, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DK0687268T3 (da) Spiroazacykliske derivater som substans P-antagonister
ES2164657T3 (es) Derivados aza-biciclicos puenteados como antagonistas de la sustancia p.
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
DE69725608D1 (de) Indolin-2-one derivate, verfahren zu ihrer herstellung und dieseenthaltende arzneimittel
MX9303263A (es) Antagonistas de la angiotensina ii, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen
ES2111492B1 (es) Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central.
AR013078A1 (es) Derivados de tetrahidroisoquinoleina, una sal de los mismos, procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de losmismos en la preparacion de un medicamento.
AR008291A1 (es) Derivados de tetrahidroisoquinolina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso para la preparacionde un medicamento.
AR002711A1 (es) Un compuesto de 2-carboxindol-3-substituido,un proceso para su preparacion, un nuevo compuesto intermediario para dicho proceso, el uso del compuesto parala fabricacion de un agente terapeutico y una composicion farmaceutica que comprende dicho compuesto.
ES2148858T3 (es) (aminoalquil- y acilaminoalquil-oxi)benciloxiquinolinas, procedimiento para su preparacion y su empleo como antagonistas de receptores de bradiquinina.
ES2106936T5 (es) Derivados de carbazolona y procedimientos para su preparacion.
IL65802A (en) 1-(3-fluoro-2-pyridinyl)piperazine and salts thereof,their preparation and pharmaceutical compositions containing them
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
FI905957A (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
KR960703401A (ko) 약학적 활성을 갖는 피리다지논 유도체[pyridazinone derivatives with pharmaceutical activity]
ES2187783T3 (es) Derivados de indolina utiles como antagonistas del receptor 5-ht-2c.
ES533937A0 (es) Un procedimiento para la preparacion de nuevos derivados de isoindol
ES2111493B1 (es) Derivados de 1-(2- (vinilo substituido ) ) -5h-2,3-benzo-diazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizaciones correspondientes.
AR014354A1 (es) Derivados de 3,4,5,6,7,8-hexahidro-pirido (3',4':4,5) tieno[2,3-d]pirimidina 3-sustituidos y su uso para la preparacion de composiciones farmaceuticas.
AR011422A1 (es) Compuestos derivados de indolil piperidinil tiadiazolo quinolein dioxido, un procedimiento para prepararlos y formulaciones farmaceuticasque los comprenden

Legal Events

Date Code Title Description
FC2A Grant refused

Effective date: 19971201

EC2A Search report published

Date of ref document: 19980301

Kind code of ref document: A1

Effective date: 19980301

FD2A Announcement of lapse in spain

Effective date: 20180806